Bellasthesin

Bellasthesin Medicine

Top 20 drugs with the same components:

Contraindications

Glaucoma, prostate adenoma.

Undesirable effects

Dry mouth, drowsiness, dizziness, mydriasis (dilated pupils), tachycardia.

Therapeutic indications

Diseases of the gastrointestinal tract, accompanied by pain, increased secretion, spasms of smooth muscles.

Pharmacotherapeutic group

  • m-Cholinolytics in combinations

Pharmacodynamic properties

The action is determined by the effects of the components that are included in the composition. Antispasmodic (lowering the tone of smooth muscle organs, including the gastrointestinal tract) and antisecretory effects (reducing the secretion of gastric, pancreatic, bronchial, salivary sweat glands and bile secretion) are due to the alkaloids of the atropine group from the extract of belladonna (hyoscyamine, scopolamine, apoatropin, etc.), analgesic (on the mucous membrane of the esophagus and stomach) — anesthetic (benzocaine).

Special precautions for storage

In a dry place, protected from light, at a temperature not exceeding 25 °C.

Keep out of reach of children.

The shelf life of the drug Bellastezin3 года.

Do not use after the expiration date indicated on the package.

Instructions for medical use Белластезин - инструкция по медицинскому применению - РУ № ЛП-002114 от 2013-06-28

Nature and contents of container

1 tablet contains extract of belladonna thick 0.015 g and anesthesin 0.3 g, in a package of 10 pcs.

Nosological classification (ICD-10)

  • K25 Stomach ulcer
  • K26 Duodenal ulcer
  • K29 Gastritis and duodenitis
  • K31. 3 Pylorospasm, not classified elsewhere
  • K81 Cholecystitis
  • R10. 1 Pain localized in the upper abdomen
  • R10. 4 Other and unspecified abdominal pain

Dosage (Posology) and method of administration

Inside, 1 tab. 2-3 times a day.

ATC - Anatomical and therapeutic chemical classification

A03ED Antispasmodics in combination with other drugs